I know you're after a serious poster, but you might have to...

I know you're after a serious poster, but you might have to settle for me.

The HER-Vaxx stage 2 trial was never completed, and the data that it did produce did not provide statistical evidence of extended overall survival vs the standard of care.

Instead of completing the trial, IMU announced 3 separate combination trials. The industry was so unimpressed with what IMU had to offer that IMU couldn't even secure free product from companies with which they proposed to run combinations. Let that sink in. IMU was prepared to pay for the clinical trials, but no one would give them free product to combine with HER-Vaxx - even though a successful combination trial would have increased the market for the combination product. Leslie had claimed that IMU was getting free product from Merck, but had to embarrassingly rectify the announcement as the ASX decided what she had announced "needed clarification" (IMO, because Leslie's announcement was B/S).

Of the three new combination trials, one was stopped after a handful of patients were recruited, two never got off the ground.

Everyone should know by now that there is no value in announcements made by Paul and Leslie. Posts get moderated if anyone straight out calls them liars, so I wont.

There is absolutely no point in quoting material released by IMU as evidence of success. Around the HER-Vaxx results time, a series of articles were published in the Financial Review, effectively calling out IMU as a meme stock. They turned out to be prescient.

IMO, IMU created a myth around HER-Vaxx ("three combination trials!", "a special BP liaison to progress a trade sale!" etc ...) so that Paul could offload some shares and IMU could raise capital to progress other initiatives before the truth about HER-Vaxx became apparent.